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Meat products are generally low in omega-3 (n-3) fatty acids, 
which are beneficial to human health. We describe the 
generation of cloned pigs that express a humanized 
Caenorhabditis e/egans gene, fat-l, encoding an n-3 fatty 
acid desaturase. The hfat-l transgenic pigs produce high levels 
of n-3 fatty acids from n-6 analogs, and their tissues have 
a significantly reduced ratio of n-6/n-3 fatty acids (P < 0.001). 
The health benefits oflong chain n-3 fatty acids, found mainly in fish 
oils, are well recognized. Meat products normally contain small 
amounts of n-3 fatty acids and large amounts of n-6 fatty acids l . 
Diets with a high ratio of n-6/n-3 fatty acids may contribute to the 
prevalence of many diseases, such as coronary artery disease, cancer, 
diabetes, arthritis and depression2. The high n-6/n-3 ratio in meat 
products is largely due to the extensive use of grains rich in n-6 t~ltty 
acids but deficient in 11-3 fatty acids as animal 
feed. In addition, livestock cannot convert 
n-6 fatty acids into /1- 3 fatty acids because 
they lack an /1-3 fatty acid desaturase gene, 
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such as the fat-l gene found in the roundworm C. clegans3. Earlier 
work in transgenic mice carrying the fat-! gene has suggested the 
feasibility of creating fat-l transgenic livestock capable of producing 
n-3 fatty acids from the corresponding n-6 fatty acids4• Here we report 
the cloning offat-1 transgenic pigs that produce high levels of /1-3 fatty 
acids in their tissues and organs. 
An hfat-l expression vector, pCAGGS-hfat-l, which contains a 
humanized fat-l eDNA (with modification of codon usage) driven 
by the cytomegalovirus enhancer and chicken ~-actin promoter, 
has been described previousll. A pgk-neo expression cassette as a 
selection marker was inserted into pCAGGS-hfat-1 to generate 
pSTl03, which was transfected into early-passage male primary 
porcine fetal fibroblast cells, pCFF4-35, by e1ectroporation; the trans-
fected cells were selected with 250 llg/ml (;418. The G418-resistant 
colonies were pooled. Gas chromatographic analysis showed that 
pCFF4-3/pST103 cells contained higher amounts of 17-3 fatty acids 
and lower amounts of n-6 fatty aeids compared with the nontrans-
feeted pCFF4-3 cells, indicating that the hfat-1 protein was functional 
in the primary porcine cells. The PCFF4-3/pST103 cells were used to 
clone hfat-l transgenic pigs by nuclear transfer as described pre-
viouslyli. A total of 1,633 reconstructed embryos were transferred into 
14 gilts that exhibited a natural estrus. Twelve early pregnancies were 
established, and five of them went to term. Twelve (ten alive and two 
dead) male piglets were born by either caesarean section or natural 
delivery. PCR analysis of DNA samples from the tails of ten live piglets 
showed that six piglets (nos. 1, 3-5, 8 and 9) were positive for the 
hfat-l transgene whereas the others (nos. 2, 7, 10 and 11) were 
negative. Most piglets appeared normal at birth, and there was no 
obviolls difference in appearance between the transgenic and non-
transgenic littermates (Supplementary Fig. 1 online). Commercial 
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Figure 1 Partial gas chromatograph traces 
showing the polyunsaturated fatty acid profiles 
of total lipids extracted from tail tissues of a 
wild-type piglet (WT, piglet no. 2) and a fat-1 
transgenic piglet (Fat-I, piglet no. 4). Both 
animals were 1 week old and fed with the same 
milk replacer. Note the levels of n-6 polyunsa-
turated acids (l8:2n-6, 20An-6, 22:4n-6 and 
22:5n-6) are lower whereas n-3 fatty acids 
(marked with', 18:3n-3, 20:5n-3, 22:5n-3 and 
22:6n-3) are abundant In the transgenic piglet 
no. 4 as compared with the nontransgenic piglet 
no. 2, in which there IS very little n-3 fatty acid. 
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Table 1 n-3 and n-6 fatty acids concentration and n-6/n-3 ratios in 
tail samples from hfat-l transgenic and wild-type piglets 
Fatty acids in tailsa Transgenic piglets (n = 8) Wild-type piglets (n = 8) 
ALA (18:3 n-3, %) 0,94 ± 0,10 0.63 ± 0.04 
EPA (20:5 n-3, %) 4.21 ± 0.60 0.26 ± 0.07 
DPA (22:5 n-3, %) l.69±0.19 0.35 ± 0.05 
DHA (22:6 n-3, %) l. 75 ± 0.23 0.95±0.21 
Total n-3 FA (%) 8.59 ± 0.84 2.18 ± 0.25 
Total n-6 FA (%) 14.28 ± 1.31 18.46 ± 1.41 
n-61 n-3 ratio 1.69 ± 0.30 8.52 ± 0.62 
Fatty acids concentration is presented as percentage of total fat In the tail samples from 
eight 2-d-old hfat-l transgenic piglets and eight age-matched wild-type piglets. Total n-6 
was calculated from linoleic acid (LA, 18:2 n-6) and arachidonic acid (AA, 20:4 n-6). 
Total n-3 fatty acids was calculated from I)(-linolenic acid (ALA, 18:3 n-3), 
eicosapentaenoic acid (EPA, 20:5 n-3), docosapentaenoic acid (DPA, 22:5 n-3), and 
docosahexaenoic acid (DHA, 22:6 n-3). Each value represented the mean ± standard 
deviation from eight tail samples in each group with two independent measurements for 
each sample. 
aStatistical analysis with two tailed t-test shows there are Significant differences between the 
transgenic and the wild-type piglet samples (P < 0.001). 
standard diets were given to recipients (gestation diet) and piglets 
(milk replacer). 
Among the six h(at-l transgenic piglets, piglets nos. 4, 5 and 8 
showed substantial differences in the fatty acid profile of their 
umbilical cord, tail and ear samples compared with their nontrans-
genic littermates. Because the piglets were cloned from a pool of 
over 100 G418-resistant colonies containing varying copy numbers of 
hfat-l at various integration sites, there was a wide range of expression 
ofhfat-l among the transgenic piglets. Figure 1 displays the fatty acid 
profile of tail samples from transgenic piglet no. 4 and nontransgenic 
piglet no. 2, It shows that all four n-3 fatty acid peaks were higher and 
all four n-6 peaks were lower in piglet no. 4 compared with piglet 
no. 2, indicating that the hfat-l transgenic piglets had efficiently 
converted n-6 fatty acids into n-3 fatty acids in their bodies. 
Piglets nos. 2, 4 and 5 were killed at 3 weeks of age because they 
developed symptoms of heart failure caused primarily by an interatrial 
septal defect. This defect has been reported in other cloned pigs6 and 
appears to be a function of the cloning process (incomplete nuclear 
reprogramming) rather than the hfat-l transgene: transgenic piglets 
nos. 8 and 9 did not have cardiac defects whereas nontransgenic piglet 
no. 2 showed the same symptoms as transgenic piglets nos. 4 and 5. In 
addition, hfat-l transgenic mice produced by pronuclei microiniec-
tion4 have been bred for many generations and show no heart failure 
symptoms (Kang et al., unpublished data). This speculation was 
further supported by characterization of a litter of eight healthy 
male piglets that were cloned from muscle fibroblasts isolated from 
piglet no. 4. As expected, all of them were hfat-l transgenic. However, 
none showed heart failure symptoms at 3 weeks of age. Table 1 shows 
the fatty acid profiles of tail samples from these eight transgenic piglets 
and eight age-matched, wild-type, control piglets. The concentrations 
of total n-3 fatty acids in tail tissues of the transgenic piglets 
were threefold higher than in the wild-type piglets. Among them, 
eicosapentaenoic acid (EPA) and docosapentaenoic acid (DPA) 
showed a 15-fold and fourfold increase, respectively. On the other 
hand, the concentration of total n-6 fatty acids in the transgenic piglets 
was reduced by 23%. Consequently, there was a fivefold reduction of 
the n-6/n-3 ratio in hjilt-l transgenic piglets compared with wild-type 
piglets (from 8.52 to 1.69, P < 0.001) (Table 1). 
The major tissues (muscle, liver, kidney, heart, spleen, tongue, brain 
and skin) from hfat-l transgenic piglets nos. 4 and 5 and non-
transgenic piglet no. 2 were collected and analyzed for n-3 and 
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n-6 fatty acids. Piglets nos. 4 and 5 showed a substantially lower 
n-6/n-3 ratio in all tissues examined compared with piglet no. 2 
(Supplementary Table 1 online). It was also shown that piglet no. 4 
had a lower n-6/n-3 ratio than piglet no. 5 in most of the tissues 
examined, indicating the heterogeneity of the cells used for nuclear 
transfer. The total n-3 fatty acids (alpha-linolenic acid (ALA), EPA, DPA 
and docosahexaenoic acid (DHA)) in skeletal muscle from the trans-
genic pigs were about 8% of total muscle fat on average, which is much 
higher than those in wild-type pigs (1-2°/(,). Thus, these results indicate 
that hfat-l transgenic pigs can produce meat enriched in n-3 fatty acids. 
Normal pork fat contains ~ 40% oleic acid, ~ 15% n-6 fatty acids 
and very little n-3 fatty acids ( ~ 1 %). Several groups have reported the 
production of n-3 fatty acid-enriched pork by feeding pigs with 
flaxseed, fish oil or fish meal7. Total n-3 fatty acids increased from 
1 % to 6% of muscle fat, a yield of 250 mg per 100 g of fresh meat. 
These results showed that an increase in ALA (18:3 n-3) alone in pork 
can affect its sensory qualities. However, an increase in long chain n-3 
fatty acids (EPA and DHA) did not affect the quality of freshly cooked 
pork? Pork quality can be affected by high intake of polyunsaturated 
fatty acids (PUFA) in the diet because it decreases the oleic acid 
content, increases the iodine value (hence oxidizability) and causes 
undesirable softening and yellowing of the carcass fae. This is unlikely 
to be an issue in the hfat-l transgenic pigs because they only convert 
n-6 PUFA to n-3 PUFA and do not need extra PUFA in their diet. 
The demand for n-3 fatty acids has increased considerably in recent 
years as evidence of their beneficial effects has grown. So far, the only 
way to enrich the tissues of mammals with n-3 fatty acids has been 
dietary provision of n-3 fatty acids. Thus, the food industry must feed 
animals with flaxseed, fish meal or other marine products. In view of 
the decline in marine fish stocks and the potential contamination of fish 
products with mercury and other chemicals, alternative, land-based 
dietary sources of n-3 fatty acids are needed. Generation of fat - I trans-
genic livestock that produce n-3 fatty acids may be an economical and 
sustainable strategy to address this need. In addition, fat-l transgenic 
pigs provide a large animal model in which to study the role of n-3 fatty 
acids in the prevention and treatment of various clinical conditions, 
such as coronary heart disease and immune-mediated disorders. 
Note: Supplementary information is available on the Nature Biotechnology website. 
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